Department of Thoracic Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.
J Cardiothorac Surg. 2020 Nov 23;15(1):332. doi: 10.1186/s13019-020-01368-9.
Langerhans cell histiocytosis (LCH) is a rare neoplastic hyperplasia with an unknown etiology. It is clinically rare for patients with solitary rib lesion and pathological fracture; moreover, its diagnosis and treatment are quite difficult. The purpose of this study is to present a case for the pathogenesis, clinical features, imaging, and treatment of this disease.
A 52-year-old female patient complained of left chest pain for one week. CT showed a fracture in the left 5th rib. The rib tumor was then resected and the surrounding muscles and soft tissues were accordingly resected. The patient was diagnosed with pathological rib fracture, and the patient was pathologically diagnosed with LCH. After surgery, no local recurrence or distant metastasis was reported during the two-year follow-up.
LCH should be treated by observation, chemotherapy, radiotherapy, or surgery, or using a combination of several methods. Moreover, primary tumor should be considered when rib fracture without trauma and tumor metastasis.
朗格汉斯细胞组织细胞增生症(LCH)是一种病因不明的罕见肿瘤性增生。患者出现单发肋骨病变及病理性骨折的临床少见,且其诊断及治疗极具难度。本研究旨在报告一例该病患者的发病机制、临床特征、影像学表现及治疗方法。
一名 52 岁女性患者因左胸痛 1 周就诊。CT 显示左侧第 5 肋骨骨折。随后切除肋骨肿瘤,并相应切除周围肌肉和软组织。患者被诊断为病理性肋骨骨折,且患者经病理诊断为 LCH。术后 2 年随访期间,未报告局部复发或远处转移。
LCH 可通过观察、化疗、放疗或手术治疗,或采用几种方法的联合治疗。此外,当无创伤性肋骨骨折且无肿瘤转移时,应考虑原发性肿瘤。